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ABSTRACT The binding of uridine vanadate to ribonuclease A has been investigated by one- and two-dimensional 'H NMR.
The homonuclear Nuclear Overhauser and exchange spectroscopy spectrum of the uridine vanadate/RNase A complex exhibits
cross peaks between both the C5H and C6H protons of uridine vanadate and the Hel proton of His-12 of ribonuclease A. These
cross peaks suggest that the HEl proton of His-12 is in the vicinity of the uracil base of uridine vanadate, as observed in the
crystallographic structure of the uridine vanadate/RNase A complex. However, no cross peaks are observed between the C5H
and C6H protons of uridine vanadate and the Hel proton of His-1 19 of ribonuclease A, although they were predicted based upon
the distances calculated from coordinates of the crystallographic structure of the complex. These results suggest that there is
a significant difference between the positioning of the His-1 19 side chain in the solution and in the crystallographic structures.
INTRODUCTION
The structure and mechanism of ribonuclease A (RNase A),
a small (13.7 kDa), highly stable enzyme that cleaves phos-
phodiester linkages in single-stranded ribonucleic acid
chains, have been extensively studied (Richards and
Wyckoff, 1971; Blackburn and Moore, 1982; Eftink and
Biltonen, 1987). Since the publication of the first 1H NMR
spectrum for this protein (Saunders et al., 1957), many of the
aromatic proton resonances have been assigned (Bradbury
and Scheraga, 1966; Meadows et al., 1968; Bradbury and
Teh, 1975; Markley, 1975a; Patel et al., 1975; Shindo et al.,
1976; Lenstra et al., 1979) as well as a number of carbon
resonances (Walters and Allerhand, 1980; Howarth and Lian,
1984). More recently, extensive assignments of backbone
proton NMR resonances of RNase A (Robertson et al., 1989;
Rico et al., 1989) have been made that confirm the assign-
ments made by previous investigators. Moreover, a close
similarity in the backbone structural elements is observed in
the crystallographic and solution structures of the enzyme.
RNase A contains four histidine residues at positions 12,
48, 105, and 119 that are clearly visible in the aromatic region
of its 1H NMR spectrum. His-12 and His-119 lie within the
active site of the enzyme (Richards and Wyckoff, 1971) and
function as acid-base donors in the enzymatic mechanism
(Findlay et al., 1962). The binding of substrates and inhibi-
tors to the enzyme is often reflected in a change in the proton
NMR resonances of these two residues (Meadows et al.,
1969; Markley, 1975b; Markley and Ulrich, 1984). Recently,
we reported the effects of replacing Asp-121 with Asn-121
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on the titration behavior of the histidines in semisynthetic
RNase A (Cederholm et al., 1991).
The two-step mechanism of RNase A begins with a
transphosphorylation reaction that produces a cyclic 2',3'-
nucleotide intermediate, followed by a hydrolysis reaction
that produces the 3'-monophosphate product. The transition
state complex of both steps contains a pentacoordinate phos-
phorus. Uridine vanadate (U-V) is an analog (Lindquist et al.,
1973) of the pentacoordinate transition state of RNase A. 1H
NMR studies (Borah et al., 1985) showed that U-V locks the
enzyme in a specific conformation at physiological pH val-
ues. The proton NMR resonances of the HEl protons of
His-12 and His-119 are each replaced by two new resonances
that have been assigned as the protonated and unprotonated
forms of the histidine resonances in a slow exchange process
(Borah et al., 1985). The present studies suggest that the
position of the His-119 side chain in this complex is sig-
nificantly different in solution and in the crystal.
MATERIALS AND METHODS
Sample preparation
U-V was prepared using the method of Borah (Borah et al., 1985). A 60.8
mM sample of uridine was dissolved in 0.3 M NaCl and 0.5 mM 2,2-
dimethyl-2-silapentane-5-sulphonate (DSS). Ammonium metavanadate was
added to a concentration of 58.1 mM, and the sample was heated at 60°C for
15 min to form the U-V complex. Because U-V forms maximally at a uridine/
vanadate ratio of about 1.2:1, the concentration of U-V is taken to be 50 mM.
An RNase A sample was prepared by dissolving 36.0 mg of the protein
(Sigma R5500, Type XII-A) into 0.32 ml of 0.3 M NaCl and 0.5 mM DSS
in D20 at pH 5.5. The concentration of this sample determined spectro-
photometrically was 8.21 mM using an extinction coefficient at 280 nm of 7.3
(Worthington Enzymes). The sample was heated at 60°C and pH 3.0 for 1 h to
exchange the backbone amide protons. A 0.08-ml aliquot of the U-V sample
prepared above was added to give a final composition of 6.57mM RNaseA and
10 mM U-V, concentrations of components that ensure enzyme saturation.
NMR measurements
All NMR measurements were carried out at 300 MHz on a Bruker AC-300
spectrometer at 30°C. The 'H-NMR spectra were recorded with the fol-
lowing parameters: block size of 16K, a 600 pulse, a 4 s relaxation delay.
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A typical spectrum was comprised of 800 scans. The two-dimensional
NOESY spectrum of the U-V/RNase A complex was recorded at pH 5.5
using a phase-sensitive mode with presaturation of solvent (Bodenhausen
et al., 1984). The spectrum was recorded in D20 with a mixing time of 200
ms. Typically, 512 t1 increments were collected, each with 2K data points
over a spectral width of 3.6 kHz in the Fl direction and 1.8 kHz in the F2
direction. All chemical shift positions are relative to the principal resonance
of 2,2-dimethyl-2-silapentane-5-sulphonate.
RESULTS AND DISCUSSION
The mechanism of RNase A that catalyzes the hydrolysis of
single-stranded ribonucleotide phosphodiesters is believed to
consist of a transphosphorylation by which the 3',5'-
phosphodiester is transesterified to a cyclic 2',3'-phosphate
and a hydrolysis by which the cyclic 2',3'-phosphate is con-
verted to a 3'-phosphate. In the transphosphorylation, His-12
acts as a base to remove a proton from the 2' oxygen of the
ribose, resulting in 02' oxygen attacking the phosphorus. In
the transition state, the phosphorus is pentacoordinate. His-
119 acts as an acid to donate a proton to the 05' end of the
phosphodiester. In the second step of hydrolysis, His-119
acts as a base to accept a proton from water and then attacks
the 2',3'-cyclic phosphate, resulting in the formation of pen-
tacoordinate phosphorus. His-12 then acts as an acid to do-
nate a proton to the 02' atom, thus forming the 3'-nucleotide
(Richards and Wyckoff, 1971; Blackburn and Moore, 1982;
Eftink and Biltonen, 1987).
The 'H NMR resonances of the HEl protons of His-105,
His-119, and His-12 of RNase A that have been previously
characterized and assigned (Bradbury and Scheraga, 1966;
Meadows et al., 1968; Bradbury and Teh, 1975; Markley,
1975; Patel et al., 1975; Shindo et al., 1976; Lenstra et al.,
1979) are shown in the 'H NMR spectrum in Fig. 1 A and
exhibit chemical shifts of 8.68, 8.61, and 8.53 ppm, respec-
tively, at pH 5.5. The resonance of the HEl proton of His-48
is only observed in the presence of acetate and propionate;
in the presence of other salts, it is not observed due to slow
exchange broadening near its pKa (Markley, 1975c). The 'H
NMR resonance of the H62 proton of His-105 is also ob-
served. However, in the presence of uridine vanadate, the 'H
NMR spectrum of RNase A is altered. The two HEl proton
resonances of His-12 and His-119 in the spectrum of RNase
A in Fig. 1 A are not observed in the spectrum of the U-V/
RNase A complex in Fig. 1 B. Instead, four new resonances
are observed at 8.84, 8.54, 7.86, and 7.45 ppm. The reso-
nances at 8.84 and 7.86 ppm have been assigned as proto-
nated and unprotonated forms of His-119, respectively, in a
slow exchange process in the pH range 5-8, and the reso-
nances at 8.54 and 7.45 ppm have been similarly assigned to
the protonated and unprotonated forms of His-12, respec-
tively (Borah et al., 1985). Thus, the 'H NMR resonances of
His-12 and His-119 change in intensity upon addition of
uridine vanadate, suggesting that His-12 and His-119 are in-
volved in complexing with uridine vanadate; in contrast, the 'H
NMR resonances ofthe HEl and H62 protons ofHis-105 are not
affected by the introduction of uridine vanadate, suggesting no
comparable role in binding to uridine vanadate.
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FIGURE 1 Proton NMR spectra at 300 MHz of (A) RNase A and (B)
RNase A in the presence of uridine vanadate (U-V) at pH 5.5. The reso-
nances of His-12 and His-119 in RNase A disappear when U-V is added to
the protein sample. Four new resonances appear at 8.84, 8.54, 7.86, and 7.45
ppm that have been attributed to the protonated and unprotonated resonances
of His-12 and His-119 (Borah et al., 1985). The resonances are labeled as
follows: 119P, His-119 protonated; 119U, His-119 unprotonated; 12P,
His-12 protonated; 12U, His-12 unprotonated; 105, His-105; H6, the proton
on the C6 atom of uridine.
The contour plot of a homonuclear NOESY spectrum of
the U-V/RNase A complex (Fig. 2) shows that cross peaks
were observed between both the C6H and C5H resonances of
U-V and the resonance assigned to the HEl proton of the
protonated form of His-12, suggesting that uridine vandate
is within approximately S A of His-12. The reason for the
absence of cross peaks corresponding to the interaction be-
tween the unprotonated form of His-12 and uridine vandate
is not clear. Moreover, no cross peaks were observed be-
tween the C6H and C5H resonances of U-V and any of the
resonances associated with His-119, indicating that uridine
vanadate is not in the vicinity of His-119. Three additional
cross peaks are observed. A cross peak is observed for the
C5H and C6H protons of uridine vanadate, which are 2.42 A
apart, based upon the coordinates of the x-ray crystallo-
graphic structure of the U-V/RNaseA complex (Borah et al.,
1985). A second cross peak is observed for a phenylalanine
resonance, possibly Phe-120, and the C6H resonance of uri-
dine vanadate, for which the distances range from 4.57 to
8.91 A (Borah et al., 1985). A third cross peak is observed
for the HEl and H82 protons of His-105, which are 4.25 A
apart (Borah et al. 1985).
The x-ray crystallographic structure of RNase crystals
grown in 60% ethanol, pH 5.2-5.7 shows well defined elec-
tron density for His-12 (Borkakoti et al., 1982); however, two
possible orientations of His-119 were observed that differ by
-1- .-
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FIGURE 2 Contour plot of phase sensitive 2D-NOE spectrum of the aro-
matic region of U-V bound to RNase A at pH 5.5. RNase A and U-V
concentrations are 6.57 and 10mM, respectively, in 0.3 M NaCl and 0.5mM
DSS in D20. The spectrum was recorded at 30'C.
rotation about the C a-co bond. In this particular structure,
position A of His-119 exhibits a torsion angle XI (N-C.-Co-
CY) of 1490, a torsion angle X2 (Ca,,C ~Cy Ca) of 1010, and
an 80% occupancy, whereas Position B of His-119 exhibits
a torsion angle xpof p690, a torsion angle x2 oft630, and
an occupancy of 20% (Fig. 3). In independent studies, the
x-ray crystallographic structure of RNase A crystals grown
in 43% t-butyl alcohol in the presence of phosphate, pH 5.3,
(Wlodawer and Sjolin, 1983) indicate that His-119 is also
primarily in position A, where the NE2 of His-l1l19 is
UV
FIGURE 3 The active site residues His-12 and His-119 of RNase A in the
presence ofuridine vanadate (Protein data bank, reference 6RSA) (Bernstein
et al., 1977; Wlodawer et al., 1983; Borah et al., 1985). In this crystallo-
graphic structure, His-119 occupies position A, which is labeled with an
upper case letter A. His-119 was modeled in position B using torsional
angles of Xl of -69°, and X2 of -63° (Borkakoti et al., 1982). The Cel
protons of the His-12, of His-119 in the position A, and His-12 in position
B, are labeled with a triangle (A); uridine vanadate is labeled as UV.
hydrogen-bonded to the side-chain oxygen ofAsp-121. Neu-
tron diffraction studies (Borah et al., 1985; Wlodawer et al.,
1983) and x-ray crystallographic studies (Alber et al., 1973)
of a complex of RNase A and the transition state analog,
uridine vandate, also place His-119 in position A. However,
when native RNase A is complexed with the inhibitor 0(3)-
-2' CMP, His- 1 9 is found primarily in position B, the sec-
ond conformation that is achieved by rotation about the
C.-C. bond (Palmer et al., 1984). As a consequence, His-19
does not hydrogen-bond to Asp-121 (Palmer et al., 1984),
and the distance from the imidazole ring of His-119 to both
the active site of the enzyme and the side chain of His-12 is
several Angstroms greater than is seen in position A (Martin
et al., 1987). In crystals of the fully active semisynthetic
ribonuclease A (Martin et al., 1987) and of the Asn-121- and
Ala-121-substituted semisynthetic ribonuclease analogs (de-
Mel et al., 1992) that were grown in ammonium sulfate, pH
5.2, His-119 occupies primarily position B.
The combined neutron and 2A resolution x-ray diffraction
analyses of the structure of the U-V/RNase A complex with
R factors of 0.199 and 0.188, respectively, (Bernstein et al.,
1977; Borah et al., 1985; Wlodawer et al. 1983) (Protein Data
Bank, reference 6RSA) indicate that the distance between the
HEl proton of His-12 and the C6H proton of U-V is 5.48 A
and that the distance between the HEl proton of His-12 and
the C5H proton of U-V is 6.68 A. Although these distances
approach the upper limit of inter-proton distances normally
observed by through-space correlation, the observation of
cross peaks suggests that on a time average, these protons are
close to each other. However, based upon the x-ray crystal-
lographic coordinates of the U-V/RNaseA complex, the dis-
tance between the HEl proton of His-i19 and C6H proton of
U-V is 4.87 A, and the distance between the HEl proton of
His-119 and C5H proton of U-V is 6.22 A. The similarity of
these distances to the distances between His-12 and U-V
suggests that if two cross peaks are observed for C6H proton
of U-V and the HEl proton of His-12, and the C5H proton of
U-V and the HEl proton of His-12, then a cross peak should
also be observed between the C6H proton of U-V and HEl
proton of His-119. The lack of such a cross peak suggests that
a significant difference exists between the crystallographic
and solution structures of the complex. When His-119 in the
x-ray crystallographic structure of the U-V/RNase A com-
plex is swung into position B with torsional angles, X1 of
-69° and X2 of -63° (Borkakoti et al., 1982), the shortest
distance between the HE1 proton ofHis- 1l9 and either proton
of uridine vanadate is 9.56 A, which would explain the ab-
sence of an observed cross peak for these resonances. Varia-
tions of X2 do not significantly reduce this value. Discrep-
ancies in the x-ray crystallographic and solution structures of
other proteins have previously been observed; however, they
usually occur on surface residues, presumably due to protein-
protein contacts found in the crystals (Bax, 1989; Wagner,
1990). The molecular packings of six crystal forms of pan-
creatic ribonuclease (Crosio et al., 1992), grown in t-butanol,
ethanol, ammonium sulfate, and polyethylene glycol 4000,
have been compared. In these six forms, active site His-19
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is observed to occur in position A or position B and is highly
solvent-accessible (Lee and Richards, 1971). The compari-
son of these six different molecular packings of RNase in-
dicates that His-119 is not involved in any intermolecular
contacts, thereby suggesting that the effects of crystal pack-
ing are not responsible for the differences in His-119 posi-
tions observed herein.
The two orientations of His-119 may be important to the
two-step mechanism ofRNase A, in which His-119 functions
first as a general acid during the transphosphorylation step
and subsequently as a general base during the hydrolysis
step. Based upon relative proximity to the apical oxygen
atom in models of RNase A complexed with the substrate
analogue, UpcA, and with the transition state analog for the
hydrolysis step, uridine vanadate, deMel and co-workers (de-
Mel et al., 1992) have postulated that His-119 is more ef-
fective during transphosphorylation when it is in position B,
and more effective in hydrolysis when in position A where
a hydrogen bond to Asp-121 enhances its basicity. Although
there is no NMR evidence to support the existence of the two
separate orientations of His-119 of RNase A in solution,
which may be due to interconversion between the two ori-
entations occurring in a sufficiently rapid time scale, NMR
data can provide evidence to support a certain orientation. A
recent report (Rico et al., 1991) describes a similar discrep-
ancy in the position of His-119 between the crystallographic
and solution structure of RNase A complexed with phos-
phate. A strong NOE between one of the methyl resonances
of Val-118 and the HEl proton of His-119 was observed,
which is not predicted by the crystallographic structure
(Borah et al., 1985) with His-119 primarily in position A; it
was concluded that His-119 might be occupying an alternate
position when phosphate is bound to the enzyme. We see a
weak interaction between one of the methyl resonances of
Val-118 and the HEl proton of His-119 of RNase A in the
presence of uridine vandate, which is expected because the
distances between these two protons range from 5.5 to 8.2 A
when His-119 is in position B, and range from 7.7 to 11.6
A when His-119 is in positionA using Protein Data Bank file
6RSA and the torsional angles listed above (Bernstein et al.,
1977; Borah et al. 1985; Wlodawer et al. 1983). The strong
NOE previously observed (Rico et al., 1991) cannot be ex-
plained in terms of His-119 simply being in position B. These
observations suggest that the position of His-119 of RNase
A is differentially affected by the presence of phosphate or
uridine vanadate. Overall, the results suggest that the position
of His-119 of RNase A in the presence of uridine vanadate
observed crystallographically differs from that observed by
NMR spectroscopy.
The observed differences in position A and B of His-119
of RNase A might be a function of differences in crystal-
lographic and solution structures; however, they might be a
result of differences in experimental conditions. The RNase
A that exhibits His-119 primarily in the A position
(Borkakoti et al., 1982; Wlodawer and Sjolin, 1983;
Wlodawer et al., 1983) was crystallized from alcohols, such
as 40-60% ethanol at pH 5.2-5.7, and 43% t-butyl alcohol
at pH 5.3; in contrast, RNase crystallized from salt solutions
such as ammonium sulfate at pH 5.2 (Martin et al., 1987;
deMel et al., 1992) exhibits His-119 in the B position. More-
over, NOE spectra of the RNase A/phosphate complex in
aqueous solution in 0.2 M NaCl at pH 4.0 show His-119
predominantly near Val-118, which abuts the B position
(Santoro et al., 1993). Our results predict that a crystallo-
graphic structure of RNase A complexed with uridine vana-
date in aqueous, ionic solution would have a significant frac-
tion of the His-119 side chain in the B position.
It has been postulated that uridine vandate is a better ana-
log of the transition state for the hydrolysis step than for the
transphosphorylation. This implies that His-119 in the uri-
dine vanadate complex should be closer to position A, which
is not observed in ourNMR experiments. Perhaps the greater
ionic strength of the NMR sample weakens the interaction
between His-119 and Asp-121 and allows the former to move
away, possibly closer to the axial oxygen, which has a larger
electrostatic potential than the equatorial ones (Krauss and
Basch, 1992).
Molecular dynamics calculations (Brooks et al., 1986)
would suggest that His-119 in the A position is important for
hydrolysis because it is hydrogen-bonded to Asp-121,
thereby making it a better base for abstracting the proton off
the water that attacks the tetrahedral phosphonate in the cy-
clic nucleotide. However, the lack of this Asp-121 hydrogen-
bonded to His-119 does not completely eliminate enzymatic
activity. The replacement of Asp-121 by Ala results in a
decrease of activity; the kIt/KM is 1.91 mM-1 s-1 for semi-
synthetic wild-type RNase A and 0.25 mM-1 s-1 for Ala-121
substituted semisynthetic RNase A (deMel et al., 1992).
Moreover, the loss of hydrogen bonding capability between
Asp-121 and methylated His-119 in semisynthetic RNase A
results in neither a change in the pKa of His-119 (Serdijn
et al., 1984a, b) nor a total loss of enzymatic activity.
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